Mayhem: Public Notification - Undeclared Drug Ingredients
Risk of impaired ability to fight infections, high blood sugar levels, muscle injuries, and psychiatric problems.
Italiano
Risk of impaired ability to fight infections, high blood sugar levels, muscle injuries, and psychiatric problems.
L'Agenzia Italiana del Farmaco rende disponibili nuove e importanti
informazioni sui medicinali, biocidi, e dispositivi medici contenenti clorexidina in soluzione cutanea per uso cutaneo nei neonati.
Ventilator may stop working after the air and oxygen gas supply lines are disconnected and then reconnected. This can lead to serious health problems or death.
Il Comitato per la Valutazione dei Rischi in Farmacovigilanza dell’EMA (PRAC) raccomanda misure per ridurre il rischio di problemi cardiaci con Corlentor / Procoralan (ivabradina).
L’Agenzia Europea dei Medicinali e l'Agenzia Italiana del Farmaco comunicano aggiornamenti relativi alla carenza temporanea di Xofigo® (radio-223 dicloruro).
Use of recalled devices may cause serious health risks, including delay in therapy, delivery of too much fluid, too high or too low blood pressure, slow or fast heart rhythm/beat, shock, trauma, 1st or 2nd degree burns, smoke inhalation, problems breathing, stroke, and death.
80.211.154.110